Skip to main content
Erschienen in: Inflammation Research 1/2019

21.08.2018 | Review

Cross talk between natural killer cells and mast cells in tumor angiogenesis

verfasst von: Domenico Ribatti, Roberto Tamma, Enrico Crivellato

Erschienen in: Inflammation Research | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Natural killer (NK) cells are large granular lymphocytes of the innate immune system, responsible for direct targeting and killing of both virally infected and transformed cells. Under pathological conditions and during inflammation, NK cells extravasate into the lymph nodes and accumulate at inflammatory or tumor sites. The activation of NK cells depends on an intricate balance between activating and inhibitory signals that determines if a target will be susceptible to NK-mediated lysis. Many experimental evidences indicate that NK cells are also involved in several immunoregulatory processes and have the ability to modulate the adaptive immune responses. Many other important aspects about NK cell biology are emerging in these last years. The aim of this review is to elucidate the role of NK cells in tumor angiogenesis and their interaction with mast cells. In fact, it has been observed that NK cells produce pro-angiogenic factors and participate alone or in cooperation with mast cells to the regulation of angiogenesis in both physiological and pathological conditions including tumors.
Literatur
1.
Zurück zum Zitat Miller JS, Verfaillie C, McGlave P. The generation of human natural killer cells from CD34+/DR− primitive progenitors in long-term bone marrow culture. Blood. 1992;80(9):2182–7.PubMed Miller JS, Verfaillie C, McGlave P. The generation of human natural killer cells from CD34+/DR− primitive progenitors in long-term bone marrow culture. Blood. 1992;80(9):2182–7.PubMed
2.
Zurück zum Zitat Bennett IM, Zatsepina O, Zamai L, Azzoni L, Mikheeva T, Perussia B. Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12. J Exp Med. 1996;184(5):1845–56.CrossRefPubMed Bennett IM, Zatsepina O, Zamai L, Azzoni L, Mikheeva T, Perussia B. Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12. J Exp Med. 1996;184(5):1845–56.CrossRefPubMed
3.
Zurück zum Zitat Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, Biassoni R, Moretta L. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol. 2001;19:197–223.CrossRefPubMed Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, Biassoni R, Moretta L. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol. 2001;19:197–223.CrossRefPubMed
4.
Zurück zum Zitat Trinchieri G. Biology of natural killer cells, advances in immunology. Amsterdam: Elsevier; 1989. pp. 187–376. Trinchieri G. Biology of natural killer cells, advances in immunology. Amsterdam: Elsevier; 1989. pp. 187–376.
5.
Zurück zum Zitat Freud AG, Caligiuri MA. Human natural killer cell development. Immunol Rev. 2006;214:56–72.CrossRefPubMed Freud AG, Caligiuri MA. Human natural killer cell development. Immunol Rev. 2006;214:56–72.CrossRefPubMed
6.
Zurück zum Zitat Timonen T, Saksela E. Isolation of human NK cells by density gradient centrifugation. J Immunol Methods. 1980;36(3–4):285–91.CrossRefPubMed Timonen T, Saksela E. Isolation of human NK cells by density gradient centrifugation. J Immunol Methods. 1980;36(3–4):285–91.CrossRefPubMed
7.
Zurück zum Zitat Young JD-E, Cohn ZA. Cellular and humoral mechanisms of cytotoxicity: structural and functional analogies. Adv Immunol. 1987;41:269–332.CrossRefPubMed Young JD-E, Cohn ZA. Cellular and humoral mechanisms of cytotoxicity: structural and functional analogies. Adv Immunol. 1987;41:269–332.CrossRefPubMed
8.
Zurück zum Zitat Carrega P, Ferlazzo G. Natural killer cell distribution and trafficking in human tissues, Front Immunol 3 (2012). Carrega P, Ferlazzo G. Natural killer cell distribution and trafficking in human tissues, Front Immunol 3 (2012).
9.
Zurück zum Zitat Cooper MA. Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset. Blood. 2001;97(10):3146–51.CrossRefPubMed Cooper MA. Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset. Blood. 2001;97(10):3146–51.CrossRefPubMed
10.
11.
Zurück zum Zitat Hayakawa Y, Smyth MJ. Innate immune recognition and suppression of tumors, advances in cancer research, Amsterdam: Elsevier; 2006. pp. 293–322. Hayakawa Y, Smyth MJ. Innate immune recognition and suppression of tumors, advances in cancer research, Amsterdam: Elsevier; 2006. pp. 293–322.
12.
Zurück zum Zitat Smyth MJ, Hayakawa Y, Takeda K, Yagita H. New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer. 2002;2(11):850–61.CrossRefPubMed Smyth MJ, Hayakawa Y, Takeda K, Yagita H. New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer. 2002;2(11):850–61.CrossRefPubMed
13.
Zurück zum Zitat Sullivan JL, Woda BA. X-linked lymphoproliferative syndrome. Immunodefic Rev. 1989;1(4):325–47.PubMed Sullivan JL, Woda BA. X-linked lymphoproliferative syndrome. Immunodefic Rev. 1989;1(4):325–47.PubMed
14.
Zurück zum Zitat Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S, Prus D, Cohen-Daniel L, Arnon TI, Manaster I, Gazit R, Yutkin V, Benharroch D, Porgador A, Keshet E, Yagel S, Mandelboim O. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med. 2006;12(9):1065–74.CrossRefPubMed Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S, Prus D, Cohen-Daniel L, Arnon TI, Manaster I, Gazit R, Yutkin V, Benharroch D, Porgador A, Keshet E, Yagel S, Mandelboim O. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med. 2006;12(9):1065–74.CrossRefPubMed
15.
16.
Zurück zum Zitat Ratsep MT, Felker AM, Kay VR, Tolusso L, Hofmann AP, Croy BA. Uterine natural killer cells: supervisors of vasculature construction in early decidua basalis. Reproduction. 2014;149(2):R91–102.CrossRefPubMed Ratsep MT, Felker AM, Kay VR, Tolusso L, Hofmann AP, Croy BA. Uterine natural killer cells: supervisors of vasculature construction in early decidua basalis. Reproduction. 2014;149(2):R91–102.CrossRefPubMed
17.
Zurück zum Zitat Krzywinska E, Kantari-Mimoun C, Kerdiles Y, Sobecki M, Isagawa T, Gotthardt D, Castells M, Haubold J, Millien C, Viel T, Tavitian B, Takeda N, Fandrey J, Vivier E, Sexl V, Stockmann C. Loss of HIF-1α in natural killer cells inhibits tumour growth by stimulating non-productive angiogenesis, Nat Commun 8(1) (2017). Krzywinska E, Kantari-Mimoun C, Kerdiles Y, Sobecki M, Isagawa T, Gotthardt D, Castells M, Haubold J, Millien C, Viel T, Tavitian B, Takeda N, Fandrey J, Vivier E, Sexl V, Stockmann C. Loss of HIF-1α in natural killer cells inhibits tumour growth by stimulating non-productive angiogenesis, Nat Commun 8(1) (2017).
18.
Zurück zum Zitat Lee H, Schlereth SL, Park EY, Emami-Naeini P, Chauhan SK, Dana R. A novel pro-angiogenic function for interferon-γ–secreting natural killer cells. Investig Opthalmol Vis Sci. 2014;55(5):2885.CrossRef Lee H, Schlereth SL, Park EY, Emami-Naeini P, Chauhan SK, Dana R. A novel pro-angiogenic function for interferon-γ–secreting natural killer cells. Investig Opthalmol Vis Sci. 2014;55(5):2885.CrossRef
19.
Zurück zum Zitat Hoeres T, Wilhelm M, Smetak M, Holzmann E, Schulze-Tanzil G, Birkmann J. Immune cells regulate VEGF signalling via release of VEGF and antagonistic soluble VEGF receptor-1. Clin Exp Immunol. 2018;192(1):54–67.CrossRefPubMedPubMedCentral Hoeres T, Wilhelm M, Smetak M, Holzmann E, Schulze-Tanzil G, Birkmann J. Immune cells regulate VEGF signalling via release of VEGF and antagonistic soluble VEGF receptor-1. Clin Exp Immunol. 2018;192(1):54–67.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Carmeliet P, Tessier-Lavigne M. Common mechanisms of nerve and blood vessel wiring. Nature. 2005;436(7048):193–200.CrossRefPubMed Carmeliet P, Tessier-Lavigne M. Common mechanisms of nerve and blood vessel wiring. Nature. 2005;436(7048):193–200.CrossRefPubMed
22.
Zurück zum Zitat Zhang J, Adams MA, Croy BA. Alterations in maternal and fetal heart functions accompany failed spiral arterial remodeling in pregnant mice. Am J Obstet Gynecol. 2011;205(5):485 e1–16.CrossRef Zhang J, Adams MA, Croy BA. Alterations in maternal and fetal heart functions accompany failed spiral arterial remodeling in pregnant mice. Am J Obstet Gynecol. 2011;205(5):485 e1–16.CrossRef
23.
Zurück zum Zitat Blois SM, Klapp BF, Barrientos G. Decidualization and angiogenesis in early pregnancy: unravelling the functions of DC and NK cells. J Reprod Immunol. 2011;88(2):86–92.CrossRefPubMed Blois SM, Klapp BF, Barrientos G. Decidualization and angiogenesis in early pregnancy: unravelling the functions of DC and NK cells. J Reprod Immunol. 2011;88(2):86–92.CrossRefPubMed
24.
Zurück zum Zitat Leonard S, Murrant C, Tayade C, Vandenheuvel M, Watering R, Croy B. Mechanisms regulating immune cell contributions to spiral artery modification—facts and hypotheses—a review. Placenta. 2006;27:40–6.CrossRef Leonard S, Murrant C, Tayade C, Vandenheuvel M, Watering R, Croy B. Mechanisms regulating immune cell contributions to spiral artery modification—facts and hypotheses—a review. Placenta. 2006;27:40–6.CrossRef
25.
Zurück zum Zitat Bruno A, Ferlazzo G, Albini A, Noonan DM. A think tank of TINK/TANKs: Tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis. J Natl Cancer Inst. 2014;106(8):1–13.CrossRef Bruno A, Ferlazzo G, Albini A, Noonan DM. A think tank of TINK/TANKs: Tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis. J Natl Cancer Inst. 2014;106(8):1–13.CrossRef
26.
Zurück zum Zitat Bruno A, Focaccetti C, Pagani A, Imperatori AS, Spagnoletti M, Rotolo N, Cantelmo AR, Franzi F, Capella C, Ferlazzo G, Mortara L, Albini A, Noonan DM. The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer. Neoplasia. 2013;15(2):133-IN7.CrossRef Bruno A, Focaccetti C, Pagani A, Imperatori AS, Spagnoletti M, Rotolo N, Cantelmo AR, Franzi F, Capella C, Ferlazzo G, Mortara L, Albini A, Noonan DM. The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer. Neoplasia. 2013;15(2):133-IN7.CrossRef
27.
Zurück zum Zitat Bruno A, Bassani B, D’Urso DG, Pitaku I, Cassinotti E, Pelosi G, Boni L, Dominioni L, Noonan DM, Mortara L, Albini A. Angiogenin and the MMP9–TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer. FASEB J. 2018:fj.201701103R. https://doi.org/10.1096/fj.201701103R.CrossRefPubMed Bruno A, Bassani B, D’Urso DG, Pitaku I, Cassinotti E, Pelosi G, Boni L, Dominioni L, Noonan DM, Mortara L, Albini A. Angiogenin and the MMP9–TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer. FASEB J. 2018:fj.201701103R. https://​doi.​org/​10.​1096/​fj.​201701103R.CrossRefPubMed
28.
Zurück zum Zitat Yao L, Sgadari C, Furuke K, Bloom ET, Teruya-Feldstein J, Tosato G. Contribution of natural killer cells to inhibition of angiogenesis by interleukin-12. Blood. 1999;93(5):1612–21.PubMed Yao L, Sgadari C, Furuke K, Bloom ET, Teruya-Feldstein J, Tosato G. Contribution of natural killer cells to inhibition of angiogenesis by interleukin-12. Blood. 1999;93(5):1612–21.PubMed
29.
Zurück zum Zitat Trinchieri G, Rengaraju M, D’Andrea A, Valiante NM, Kubin M, Aste M, Chehimi J. Producer cells of interleukin 12. Parasitol Today. 1993;9(3):97.CrossRefPubMed Trinchieri G, Rengaraju M, D’Andrea A, Valiante NM, Kubin M, Aste M, Chehimi J. Producer cells of interleukin 12. Parasitol Today. 1993;9(3):97.CrossRefPubMed
30.
Zurück zum Zitat Cavallo F, Quaglino E, Cifaldi L, Di Carlo E, Andre A, Bernabei P, Musiani P, Forni G, Calogero RA. Interleukin 12-activated lymphocytes influence tumor genetic programs. Cancer Res. 2001;61(8):3518–23.PubMed Cavallo F, Quaglino E, Cifaldi L, Di Carlo E, Andre A, Bernabei P, Musiani P, Forni G, Calogero RA. Interleukin 12-activated lymphocytes influence tumor genetic programs. Cancer Res. 2001;61(8):3518–23.PubMed
31.
Zurück zum Zitat Gotthardt D, Putz EM, Grundschober E, Prchal-Murphy M, Straka E, Kudweis P, Heller G, Bago-Horvath Z, Witalisz-Siepracka A, Cumaraswamy AA, Gunning PT, Strobl B, Mu ller M, Moriggl R, Stockmann C, Sexl V. STAT5 is a key regulator in NK cells and acts as a molecular switch from tumor surveillance to tumor promotion. Cancer Discov. 2016;6(4):414–29.CrossRefPubMed Gotthardt D, Putz EM, Grundschober E, Prchal-Murphy M, Straka E, Kudweis P, Heller G, Bago-Horvath Z, Witalisz-Siepracka A, Cumaraswamy AA, Gunning PT, Strobl B, Mu ller M, Moriggl R, Stockmann C, Sexl V. STAT5 is a key regulator in NK cells and acts as a molecular switch from tumor surveillance to tumor promotion. Cancer Discov. 2016;6(4):414–29.CrossRefPubMed
32.
Zurück zum Zitat Ribatti D. Mast cells and macrophages exert beneficial and detrimental effects on tumor progression and angiogenesis. Immunol Lett. 2013;152(2):83–8.CrossRefPubMed Ribatti D. Mast cells and macrophages exert beneficial and detrimental effects on tumor progression and angiogenesis. Immunol Lett. 2013;152(2):83–8.CrossRefPubMed
33.
Zurück zum Zitat Gruber BL, Marchese MJ, Kiely J, Schwartz LB, Schecter NM. 520 Human mast cell products degrade connective tissue matrix. J Allergy Clin Immunol. 1988;81(1):298.CrossRef Gruber BL, Marchese MJ, Kiely J, Schwartz LB, Schecter NM. 520 Human mast cell products degrade connective tissue matrix. J Allergy Clin Immunol. 1988;81(1):298.CrossRef
34.
Zurück zum Zitat Detoraki A, Staiano RI, Granata F, Giannattasio G, Prevete N, de Paulis A, Ribatti D, Genovese A, Triggiani M, Marone G. Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects. J Allergy Clin Immunol. 2009;123(5):1142–9.e5.CrossRefPubMed Detoraki A, Staiano RI, Granata F, Giannattasio G, Prevete N, de Paulis A, Ribatti D, Genovese A, Triggiani M, Marone G. Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects. J Allergy Clin Immunol. 2009;123(5):1142–9.e5.CrossRefPubMed
35.
Zurück zum Zitat Ribatti D, Crivellato E, Candussio L, Nico B, Vacca A, Roncali L, Dammacco F. Mast cells and their secretory granules are angiogenic in the chick embryo chorioallantoic membrane. Clin Exp Allergy. 2001;31(4):602–8.CrossRefPubMed Ribatti D, Crivellato E, Candussio L, Nico B, Vacca A, Roncali L, Dammacco F. Mast cells and their secretory granules are angiogenic in the chick embryo chorioallantoic membrane. Clin Exp Allergy. 2001;31(4):602–8.CrossRefPubMed
36.
Zurück zum Zitat Norrby K, Jakobsson A, Sörbo J. Mast-cell-mediated angiogenesis: a novel experimental model using the rat mesentery. Virchows Arch B Cell Pathol Incl Mol Pathol. 1986;52(1):195–206.CrossRefPubMed Norrby K, Jakobsson A, Sörbo J. Mast-cell-mediated angiogenesis: a novel experimental model using the rat mesentery. Virchows Arch B Cell Pathol Incl Mol Pathol. 1986;52(1):195–206.CrossRefPubMed
37.
Zurück zum Zitat Norrby K, Jakobsson A, Sörbo J. Mast-cell secretion and angiogenesis, a quantitative study in rats and mice. Virchows Arch B Cell Pathol Incl Mol Pathol. 1989;57(1):251–6.CrossRefPubMed Norrby K, Jakobsson A, Sörbo J. Mast-cell secretion and angiogenesis, a quantitative study in rats and mice. Virchows Arch B Cell Pathol Incl Mol Pathol. 1989;57(1):251–6.CrossRefPubMed
38.
Zurück zum Zitat Ribatti D, Crivellato E. Mast cells, angiogenesis, and tumour growth. Biochim Biophys Acta. 2012;1822(1):2–8.CrossRefPubMed Ribatti D, Crivellato E. Mast cells, angiogenesis, and tumour growth. Biochim Biophys Acta. 2012;1822(1):2–8.CrossRefPubMed
39.
Zurück zum Zitat Williams NS, Moore TA, Schatzle JD, Puzanov IJ, Sivakumar PV, Zlotnik A, Bennett M, Kumar V. Generation of lytic natural killer 1.1+, Ly-49-cells from multipotential murine bone marrow progenitors in a stroma-free culture: definition of cytokine requirements and developmental intermediates. J Exp Med. 1997;186(9):1609–14.CrossRefPubMedPubMedCentral Williams NS, Moore TA, Schatzle JD, Puzanov IJ, Sivakumar PV, Zlotnik A, Bennett M, Kumar V. Generation of lytic natural killer 1.1+, Ly-49-cells from multipotential murine bone marrow progenitors in a stroma-free culture: definition of cytokine requirements and developmental intermediates. J Exp Med. 1997;186(9):1609–14.CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Kusaka Y, Sato K, Zhang Q, Morita A, Kasahara T, Yanagihara Y. Association of natural killer cell activity with serum IgE. Int Arch Allergy Immunol. 1997;112(4):331–5.CrossRefPubMed Kusaka Y, Sato K, Zhang Q, Morita A, Kasahara T, Yanagihara Y. Association of natural killer cell activity with serum IgE. Int Arch Allergy Immunol. 1997;112(4):331–5.CrossRefPubMed
41.
Zurück zum Zitat Arase N, Arase H, Hirano S, Yokosuka T, Sakurai D, Saito T. IgE-mediated activation of NK cells through Fc RIII. J Immunol. 2003;170(6):3054–8.CrossRefPubMed Arase N, Arase H, Hirano S, Yokosuka T, Sakurai D, Saito T. IgE-mediated activation of NK cells through Fc RIII. J Immunol. 2003;170(6):3054–8.CrossRefPubMed
42.
Zurück zum Zitat Meyer N, Woidacki K, Knöfler M, Meinhardt G, Nowak D, Velicky P, Pollheimer J, Zenclussen AC. Chymase-producing cells of the innate immune system are required for decidual vascular remodeling and fetal growth. Sci Rep. 2017;22(7):45106.CrossRef Meyer N, Woidacki K, Knöfler M, Meinhardt G, Nowak D, Velicky P, Pollheimer J, Zenclussen AC. Chymase-producing cells of the innate immune system are required for decidual vascular remodeling and fetal growth. Sci Rep. 2017;22(7):45106.CrossRef
43.
Zurück zum Zitat St. John AL, Rathore APS, Yap H, Ng ML, Metcalfe DD, Vasudevan SG, Abraham SN. Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance. 2011;Proc Natl Acad Sci 108(22):9190–9195.CrossRefPubMed St. John AL, Rathore APS, Yap H, Ng ML, Metcalfe DD, Vasudevan SG, Abraham SN. Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance. 2011;Proc Natl Acad Sci 108(22):9190–9195.CrossRefPubMed
44.
Zurück zum Zitat Burke SM, Issekutz TB, Mohan K, Lee PWK, Shmulevitz M, Marshall JS. Human mast cell activation with virus-associated stimuli leads to the selective chemotaxis of natural killer cells by a CXCL8-dependent mechanism. Blood. 2008;111(12):5467–76.CrossRefPubMed Burke SM, Issekutz TB, Mohan K, Lee PWK, Shmulevitz M, Marshall JS. Human mast cell activation with virus-associated stimuli leads to the selective chemotaxis of natural killer cells by a CXCL8-dependent mechanism. Blood. 2008;111(12):5467–76.CrossRefPubMed
45.
Zurück zum Zitat Portales-Cervantes L, Haidl ID, Lee PW, Marshall JS. Virus-infected human mast cells enhance natural killer cell functions. J Innate Immunity. 2016;9(1):94–108.CrossRef Portales-Cervantes L, Haidl ID, Lee PW, Marshall JS. Virus-infected human mast cells enhance natural killer cell functions. J Innate Immunity. 2016;9(1):94–108.CrossRef
46.
Zurück zum Zitat Vosskuhl K, Greten TF, Manns MP, Korangy F, Wedemeyer J. Lipopolysaccharide-mediated mast cell activation induces IFN- secretion by NK cells. J Immunol. 2010;185(1):119–25.CrossRefPubMed Vosskuhl K, Greten TF, Manns MP, Korangy F, Wedemeyer J. Lipopolysaccharide-mediated mast cell activation induces IFN- secretion by NK cells. J Immunol. 2010;185(1):119–25.CrossRefPubMed
47.
Zurück zum Zitat Huang B, Lei Z, Zhang GM, Li D, Song C, Li B, Liu Y, Yuan Y, Unkeless J, Xiong H, Feng ZH. SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood. 2008;112(4):1269–79.CrossRefPubMedPubMedCentral Huang B, Lei Z, Zhang GM, Li D, Song C, Li B, Liu Y, Yuan Y, Unkeless J, Xiong H, Feng ZH. SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood. 2008;112(4):1269–79.CrossRefPubMedPubMedCentral
48.
Zurück zum Zitat Oldford SA, Haidl ID, Howatt MA, Leiva CA, Johnston B, Marshall JS. A critical role for mast cells and mast cell-derived IL-6 in TLR2-mediated inhibition of tumor growth. J Immunol. 2010;185(11):7067–76.CrossRefPubMed Oldford SA, Haidl ID, Howatt MA, Leiva CA, Johnston B, Marshall JS. A critical role for mast cells and mast cell-derived IL-6 in TLR2-mediated inhibition of tumor growth. J Immunol. 2010;185(11):7067–76.CrossRefPubMed
Metadaten
Titel
Cross talk between natural killer cells and mast cells in tumor angiogenesis
verfasst von
Domenico Ribatti
Roberto Tamma
Enrico Crivellato
Publikationsdatum
21.08.2018
Verlag
Springer International Publishing
Erschienen in
Inflammation Research / Ausgabe 1/2019
Print ISSN: 1023-3830
Elektronische ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-018-1181-4

Weitere Artikel der Ausgabe 1/2019

Inflammation Research 1/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.